FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005329625> ?p ?o ?g. }

• W3005329625 endingPage "495" @default.
• W3005329625 startingPage "482" @default.
• W3005329625 abstract "TP53 mutations are associated with adverse outcomes and shorter response to hypomethylating agents (HMAs) in myelodysplastic syndrome (MDS). Limited data have evaluated the impact of the type, number, and patterns of TP53 mutations in response outcomes and prognosis of MDS. We evaluated the clinicopathologic characteristics, outcomes, and response to therapy of 261 patients with MDS and TP53 mutations. Median age was 68 years (range, 18-80 years). A total of 217 patients (83%) had a complex karyotype. TP53 mutations were detected at a median variant allele frequency (VAF) of 0.39 (range, 0.01-0.94). TP53 deletion was associated with lower overall response rate (ORR) (odds ratio, 0.3; P = .021), and lower TP53 VAF correlated with higher ORR to HMAs. Increase in TP53 VAF at the time of transformation was observed in 13 patients (61%), and previously undetectable mutations were observed in 15 patients (65%). TP53 VAF was associated with worse prognosis (hazard ratio, 1.02 per 1% VAF increase; 95% confidence interval, 1.01-1.03; P < .001). Integration of TP53 VAF and karyotypic complexity identified prognostic subgroups within TP53-mutant MDS. We developed a multivariable model for overall survival that included the revised International Prognostic Scoring System (IPSS-R) categories and TP53 VAF. Total score for each patient was calculated as follows: VAF TP53 + 13 × IPSS-R blast score + 16 × IPSS-R cytogenetic score + 28 × IPSS-R hemoglobin score + 46 × IPSS-R platelet score. Use of this model identified 4 prognostic subgroups with median survival times of not reached, 42.2, 21.9, and 9.2 months. These data suggest that outcomes of patients with TP53-mutated MDS are heterogeneous and that transformation may be driven not only by TP53 but also by other factors." @default.
• W3005329625 created "2020-02-14" @default.
• W3005329625 creator A5000750846 @default.
• W3005329625 creator A5005878960 @default.
• W3005329625 creator A5008503600 @default.
• W3005329625 creator A5010663972 @default.
• W3005329625 creator A5020340537 @default.
• W3005329625 creator A5022647201 @default.
• W3005329625 creator A5028081179 @default.
• W3005329625 creator A5028622482 @default.
• W3005329625 creator A5029750735 @default.
• W3005329625 creator A5034382901 @default.
• W3005329625 creator A5035605515 @default.
• W3005329625 creator A5036349678 @default.
• W3005329625 creator A5048285635 @default.
• W3005329625 creator A5049385583 @default.
• W3005329625 creator A5051949215 @default.
• W3005329625 creator A5059373442 @default.
• W3005329625 creator A5061026876 @default.
• W3005329625 creator A5070065917 @default.
• W3005329625 creator A5070904381 @default.
• W3005329625 creator A5083793750 @default.
• W3005329625 creator A5084379902 @default.
• W3005329625 creator A5088307376 @default.
• W3005329625 date "2020-02-06" @default.
• W3005329625 modified "2023-10-15" @default.
• W3005329625 title "Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes" @default.
• W3005329625 cites W187238933 @default.
• W3005329625 cites W1889574318 @default.
• W3005329625 cites W1966841369 @default.
• W3005329625 cites W1993236149 @default.
• W3005329625 cites W1995068068 @default.
• W3005329625 cites W2026134786 @default.
• W3005329625 cites W2027672647 @default.
• W3005329625 cites W2062135903 @default.
• W3005329625 cites W2070152906 @default.
• W3005329625 cites W2077107335 @default.
• W3005329625 cites W2129510594 @default.
• W3005329625 cites W2191233876 @default.
• W3005329625 cites W2293963033 @default.
• W3005329625 cites W2304376138 @default.
• W3005329625 cites W2326726820 @default.
• W3005329625 cites W2339658711 @default.
• W3005329625 cites W2343955238 @default.
• W3005329625 cites W2435453758 @default.
• W3005329625 cites W2466391332 @default.
• W3005329625 cites W2513269552 @default.
• W3005329625 cites W2549790759 @default.
• W3005329625 cites W2582619970 @default.
• W3005329625 cites W2587066646 @default.
• W3005329625 cites W2589411765 @default.
• W3005329625 cites W2752942423 @default.
• W3005329625 cites W2753959354 @default.
• W3005329625 cites W2759444489 @default.
• W3005329625 cites W2772063923 @default.
• W3005329625 cites W2782472025 @default.
• W3005329625 cites W2802436790 @default.
• W3005329625 cites W2908744276 @default.
• W3005329625 cites W2910041900 @default.
• W3005329625 cites W2944898189 @default.
• W3005329625 cites W4293241248 @default.
• W3005329625 doi "https://doi.org/10.1182/bloodadvances.2019001101" @default.
• W3005329625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7013259" @default.
• W3005329625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32027746" @default.
• W3005329625 hasPublicationYear "2020" @default.
• W3005329625 type Work @default.
• W3005329625 sameAs 3005329625 @default.
• W3005329625 citedByCount "78" @default.
• W3005329625 countsByYear W30053296252020 @default.
• W3005329625 countsByYear W30053296252021 @default.
• W3005329625 countsByYear W30053296252022 @default.
• W3005329625 countsByYear W30053296252023 @default.
• W3005329625 crossrefType "journal-article" @default.
• W3005329625 hasAuthorship W3005329625A5000750846 @default.
• W3005329625 hasAuthorship W3005329625A5005878960 @default.
• W3005329625 hasAuthorship W3005329625A5008503600 @default.
• W3005329625 hasAuthorship W3005329625A5010663972 @default.
• W3005329625 hasAuthorship W3005329625A5020340537 @default.
• W3005329625 hasAuthorship W3005329625A5022647201 @default.
• W3005329625 hasAuthorship W3005329625A5028081179 @default.
• W3005329625 hasAuthorship W3005329625A5028622482 @default.
• W3005329625 hasAuthorship W3005329625A5029750735 @default.
• W3005329625 hasAuthorship W3005329625A5034382901 @default.
• W3005329625 hasAuthorship W3005329625A5035605515 @default.
• W3005329625 hasAuthorship W3005329625A5036349678 @default.
• W3005329625 hasAuthorship W3005329625A5048285635 @default.
• W3005329625 hasAuthorship W3005329625A5049385583 @default.
• W3005329625 hasAuthorship W3005329625A5051949215 @default.
• W3005329625 hasAuthorship W3005329625A5059373442 @default.
• W3005329625 hasAuthorship W3005329625A5061026876 @default.
• W3005329625 hasAuthorship W3005329625A5070065917 @default.
• W3005329625 hasAuthorship W3005329625A5070904381 @default.
• W3005329625 hasAuthorship W3005329625A5083793750 @default.
• W3005329625 hasAuthorship W3005329625A5084379902 @default.
• W3005329625 hasAuthorship W3005329625A5088307376 @default.
• W3005329625 hasBestOaLocation W30053296251 @default.
• W3005329625 hasConcept C104317684 @default.
• W3005329625 hasConcept C126322002 @default.

• next